SciELO - Scientific Electronic Library Online

 
vol.14 issue2Correlation of Thyroid Imaging Reporting and Data System [TI-RADS] and fine needle aspiration: experience in 1,000 nodulesInitial experience with hysteroscopic tubal occlusion (Essure®) author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Einstein (São Paulo)

Print version ISSN 1679-4508On-line version ISSN 2317-6385

Einstein (São Paulo) vol.14 no.2 São Paulo Apr./June 2016

https://doi.org/10.1590/S1679-45082016AO3661 

Original Article

Endovascular revascularization of TASC C and D femoropopliteal occlusive disease using carbon dioxide as contrast

Cynthia de Almeida Mendes1 

Marcelo Passos Teivelis1 

Sergio Kuzniec1 

Juliana Maria Fukuda1 

Nelson Wolosker1 

1 Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.


ABSTRACT

Objective

To analyze the results of ten angioplasties of TASC C and D femoropopliteal lesions using CO2 as primary contrast in patients with no formal contraindication to iodine, aiming to decrease allergic reactions and potential nephrotoxicity in high-risk patients.

Methods

We describe the results of ten angioplasties of TASC C and D femoropopliteal lesions using CO2 as primary contrast in patients with high risk for open revascularization and no formal contraindication to iodine. We analyzed feasibility of the procedures, complications, quality of the angiographic images, clinical and surgical outcomes, and costs of C and D lesions treated using CO2 as contrast medium.

Results

The use of CO2 in C and D lesions needed iodine complementation in most of the cases (nine cases) but decreased the potential nephrotoxicity of iodine contrast medium by the reduction of its volume in this group of high-risk patients. The extension of the arterial lesions was the factor that most contributed to the need for iodine supplementation due to the difficulty to visualize the refill after a long arterial occlusion.

Conclusion

The use of CO2 as contrast in patients with C and D lesions with no restriction for iodine contrast medium was an alternative that did not dismiss the need of iodine supplementation in most of the cases, but could decrease the potential nephrotoxicity of iodine constrast medium.

Key words: Angioplasty; Renal insufficiency; Peripheral arterial disease; Carbon dioxide; Endovascular procedures

RESUMO

Objetivo

Analisar os resultados de dez angioplastias de lesões fêmoro-poplíteas TASC C e D utilizando CO2 como meio de contraste primário em pacientes sem restrição ao meio de contraste iodado com o objetivo de diminuir reações alérgicas e potencial de nefrotoxicidade em pacientes de alto risco.

Métodos

Descrevemos os resultados de dez angioplastias de lesões fêmoro-poplíteas TASC C e D utilizando CO2 como meio de contraste primário em pacientes de alto risco para revascularização aberta e sem contraindicação formal a iodo. Analisamos possibilidade de execução dos procedimentos, complicações, qualidade das imagens obtidas, desfechos clínicos e cirúrgicos e custos das lesões C e D tratadas com CO2 como meio de contraste.

Resultados

O uso de CO2 nas lesões C e D necessitou de complementação de iodo na maioria dos casos (nove casos), porém reduziu o potencial de nefrotoxicidade do meio de contraste iodado, diminuindo seu volume nesse grupo de pacientes de alto risco. A extensão das lesões arteriais foi o fator que mais contribuiu para necessidade de suplementação de iodo, devido à dificuldade de visualizar o reenchimento após oclusão arterial longa.

Conclusão

O uso de CO2 como contraste em pacientes com lesões C e D sem restrição ao meio de contraste iodado foi uma alternativa que não excluiu a necessidade de suplementação com iodo na maioria dos casos, porém pôde diminuir o potencial de nefrotoxicidade do meio de contraste iodado.

Palavras-Chave: Angioplastia; Insuficiência renal; Doença arterial periférica; Dióxido de carbono; Procedimentos endovasculares

INTRODUCTION

Revascularization is the treatment of choice in cases of critical limb ischemia and it can be accomplished by open surgery or endovascular procedures, depending on the extent of lesions and clinical conditions of the patient.(1) According to the 2007 Trans-Atlantic Inter-Society Consensus (TASC) II, for TASC A and B lesions, percutaneous transluminal angioplasty is the preferred treatment, and surgical bypass is recommended for good-risk patients with TASC C and D lesions.(2) Many patients with TASC C and D lesions are considered to have high risk for surgical bypass due to medical comorbidities and therefore depend on endovascular techniques for revascularization. With the improvement of the technique in endovascular procedures and technological advances, currently many centers are using endovascular therapy as the primary treatment for TASC C and D lesions and reserving surgical therapy for failed endovascular intervention.(3)

Endovascular interventions for TASC D lesions can be safely performed with good hemodynamic improvement and limb salvage rates.(4) Recent studies suggest that the “endovascular first” approach for TASC C and D is a reasonable option, with 68% patency rate at six months.(5)

Iodine contrast medium (ICM) is considered gold standard in endovascular procedures. However nephrotoxicity and hypersensitivity to ICM are causes for concern that limit its indiscriminate use.(6,7)

The use of carbon dioxide (CO2) is currently considered as a good alternative for aortic,(8) aortoiliac,(9) and femoropopliteal procedures(10) in patients with formal contraindication to ICM. CO2 has also been used in femoropopliteal angioplasties of TASC A and B lesions in patients with no contraindication to iodine with good results.(11) Specific research for the endovascular treatment of TASC C and D lesions has not yet been conducted.

OBJECTIVE

To analyze the results of ten angioplasties of TASC C and D femoropopliteal lesions using CO2 as primary contrast in patients with no formal contraindication to iodine, aiming to decrease allergic reactions and potential nephrotoxicity in high-risk patients.

METHODS

From June 2012 to September 2013, ten patients with peripheral arterial disease, arterial lesions classified as TASC C or D, and adequate runoff (identified on preoperative computed tomography angiography) underwent femoropopliteal revascularization by endovascular technique. All of them had critical limb ischemia with gangrene, and all were considered as high operative risk for surgical bypass. None of the patients exhibited severe chronic obstructive pulmonary disease. The Ethics Committee for Analysis of Research Projects on Human Experimentation approved this study at our institution, CAAE: 15117914.3.0000.0071, and all the patients signed Informed Consent Terms.

Table 1 shows the demographic and clinical profile of the patients in our study sample.

Table 1 Demographic and clinical profile of patients 

Age average, years (SD) 79 (7.07)
Age range, years 55-78
Male gender (%) 7 (70)
BMI average, kg/m2 (range) 25.5 (21.5-30.7)
Hypertension (%) 9 (90)
Diabetes (%) 7 (70)
Dyslipidemia (%) 1 (10)
History of tobacco use (%) 3 (30)
Coronary disease (%) 2 (20)

SD: standard deviation; BMI: body mass index.

All procedures were performed in an endovascular suite operating (Philips Allura Xper FD, Netherlands) room under general anesthesia with cardiac monitoring, invasive arterial pressure monitoring, and bladder catheterization.

The patients underwent femoropopliteal angioplasties by the same surgical team using a constant surgical technique throughout the study. A 40-degree Trendelenburg tilt was maintained throughout the procedure.

Ipsilateral puncture of the common femoral artery was used as access in nine out of the ten patients. In one case, due to accidental loss of the ipsilateral puncture, a contralateral approach was used.

After arterial puncture and insertion of a 6F introducer access sheath, systemic heparinization (70U/kg) was performed followed by initial angiography. The lesion was crossed using catheters and hydrophilic guidewires, followed by dilatation with balloon angioplasty and new control angiography to evaluate the need for stenting. At the end of the procedure, heparinization was reversed with protamine, and local manual compression was carried out for 30 minutes after removal of the introducer.

Immediately after the operation, on a routine basis in the service, all patients were referred to the Intensive Care Unit for at least 24 hours, and received intravenous fluids following a fixed protocol for renal protection. Thereafter patients remained hospitalized for the time needed, with daily monitoring of renal function, blood count, and electrolytes for at least 72 hours.

The CO2 injection was performed manually, without any specific pump system. A cylinder with medicinal CO2, a particle filter (Millex® Durapore® hydrophilic 0.22μm pore), and a three-way stopcock were used for aspiration of CO2 and the entire procedure was held inside a bowl with saline solution. After capturing the required volume of CO2, additional 3 to 5mL of saline solution were aspired into the syringe to provide a water seal while the tip was kept down. Thus, a physical barrier was created between the room air and the CO2 content, which is independent of manual compression and is safe of air contamination.(12) We used 10mL and 20mL syringes for the intra-arterial contrast injection, performed into the femoral introducer or through an end hole catheter.

The injection of ICM, when needed, was performed manually in 10mL syringes using 3mL of iodinated contrast media and 7mL of saline solution per injection.

The endovascular material (sheaths, guidewires, and stents) used in all procedures was provided by Cook Medical Inc. The material used in each intervention and the volumes of CO2 and ICM were precisely recorded for further analysis.

All the procedures were recorded on DVD for further analysis by two observers who did not take part in the intervention and who had no experience with the use of CO2. Both observers analyzed each film separately.

Observers attributed a score for each evaluated image ranging from 1 to 3. The score 1, considered poor, was attributed when there was significant loss of definition in the vessels and/or collateral circulation which precluded the procedure; the score 2, considered fair, was attributed when there was some loss of definition in the vessels and/or collateral circulation, but did no hinder intervention; the score 3, considered good, was assigned when there was good contrast in the vessels and collateral circulation.

An individual analysis was carried out for each intervention, evaluating costs related to the contrast media and endovascular material used (puncture needles, sheaths, angioplasty balloons, catheters, insufflating syringes, and stents). It is relevant to emphasize that, since ICM is required for balloon filling during angioplasties, we added the price of one 20mL flask of ICM to all the patients who demanded no or less than 20mL of iodinated contrast.

We evaluated the following outcomes: feasibility of the procedures; complications; surgical outcomes (ankle-brachial index − ABI variation, frequency of major amputation in 30 days); creatinine clearance rate using the Cockcroft-Gault formula;(13) quality of the angiographic images obtained with CO2; costs of the endovascular materials; and costs of contrast agents.

Statistical analysis

Categorical variables were described as absolute frequencies and percentages. The distribution of numerical variables was investigated by histograms and normality Shapiro-Wilk tests. Numerical data were described by means and standard deviations (SD) or medians and interquartile ranges (first quartile to third quartile) in the case of non-normally distributed data.

Statistical analysis was performed using Statistical Package for Social Science (SPSS) released in 2008, for Windows, version 17.0. The level of significance used was 5%.

RESULTS

Nine patients had TASC D lesions, and one patient had a TASC C lesion. All of them had critical limb ischemia with gangrene, and all were considered as high operative risk for surgical bypass.

There were no CO2 related complications. The injected volume of CO2 required for each procedure ranged from 12 to 146mL (mean of 70.35mL; SD of 40.5).

In nine patients (one TASC C and eight TASC D), the use of iodine was necessary for completion of the procedure. In these cases, the iodine use was justified by difficulty in visualizing refill after occlusion. The mean volume of ICM used per patient was 11.9mL, ranging from 5 to 23mL (mean of 11.9mL; SD of 7.7). In five cases, the volume of ICM used was inferior to 10mL, and in the other four cases, less than 25mL.

We were able to perform the proposed procedures, with successful target vessel revascularization, in six of ten patients treated in this series.

All the patients in whom the procedure could not be completed had TASC D lesions. In two of them, we could not accomplish the guidewire re-entry into the arterial tree after the occluded segment, and we did not have re-entry devices in our service. In one case, there was no adequate runoff, despite preoperative computed tomography angiography suggesting otherwise.

In the last unsuccessful case, there was a slow contrast flow in the distal arterial bed, probably by distal embolization. This patient underwent femoropedal bypass in postoperative day one, but this procedure was not successful as well, and major amputation (above the knee) was performed within 30 days of intervention.

Two out of the ten patients presented with acute myocardial infarction and one of them died as a result of cardiac complications, occurring within 30 days of intervention.

The duration of the procedures did not exceed three hours in neither of the patients.

Operative details, including costs of endovascular material, contrast costs, fluoroscopy time, duration of the procedures, variations in creatinine clearance levels, and ABI of all patients are shown in tables 2 and 3.

Table 2 Operative details 

Patient TASC classification Preoperative creatinine clearance Postoperative creatinine clearance Preoperative ABI Postoperative ABI Duration of surgery (minutes)
1 D 25.86 28.95 0 0.2 80
2 D 40.37 74.53 0.2 0.33 180
3 D 45.69 55.57 0.1 0.2 120
4 D 73.35 87.71 0.5 0.6 130
5 D 28.65 42.89 0.4 0.45 130
6 D 29.85 36.55 0.57 0.21 105
7 D 80 101.49 0 0 180
8 D 60.1 38.89 0.47 0.87 75
9 D 52.5 44.44 0 0.56 75
10 C 110.38 100.34 0.25 0.6 100

TASC: Trans-Atlantic Inter-Society Consensus; ABI: ankle-brachial index.

Table 3 Operative details 

Patient CO2 volume (mL) ICM volume (mL) Endovascular material cost (US Dollar) Contrast cost (US Dollar) Technical success
1 45 23 1,472 20.12 No
2 58 9 3,002 10.12 Yes
3 41 9 8,417 10.12 Yes
4 78 9 9,042 10.12 Yes
5 56 0 7,362 10.12 Yes
6 85 15 1,667 10.12 No
7 146 7 23,112 10.12 No
8 127.5 5 15,142 10.12 Yes
9 55 21 3,442 20.12 No
10 12 21 5,372 20.12 Yes

CO2: carbon dioxide; ICM: iodine contrast medium.

The evaluation of angiographies by the two observers is presented in table 4.

Table 4 Evaluation of angiographies by observers 

Observer CO2 arteriography

Good Fair Poor
1 4 4 2
2 3 7 0

CO2: carbon dioxide.

CO2 arteriograms were graded as good or fair by both observers with high interobserver image quality agreement. Only two images were graded as poor.

Additionally, after six months of follow-up, two other patients underwent major amputation (one in which we did not have initial technical success and was deemed as high-risk for open revascularization, and the other one that suffered occlusion of the stent and was as well deemed as high-risk for surgical revascularization). The remaining seven patients were alive and free of amputation. Figure 1 illustrates a CO2 arteriography.

Figure 1 Example of a carbon dioxide arteriography 

DISCUSSION

Endovascular surgery has an increasingly important place in the revascularization of the lower limbs. The “endovascular first” approach is already a reality in many centers. Patients with severe chronic arterial occlusive disease and extensive lesions classified as TASC C and D have the chance of limb salvage attempt with endovascular surgery. These are complex patients with extensive arterial lesions and often with very serious clinical comorbidities, making them at high risk for open limb revascularization. Frequently the endovascular surgery is the only option for limb salvage attempt.

In this series of cases, we simultaneously had technical difficulty of an endovascular approach of TASC C and D lesions and the attempt to do this procedure with an intravascular contrast different than the usual. Our group already had the experience with the use of CO2 in TASC A and B lesions with good results. Therefore aiming to investigate the possibility of a wider use for CO2, we sought to establish the effectiveness of CO2 in patients with femoropopliteal TASC C and D lesions, initially in patients who presented with no contraindication to ICM, as if the complementation with iodine was necessary, it would not be problematic.

Our results showed that the use of CO2 in TASC C and D lesions needed iodine complementation in most of the cases (nine out of ten). The extension of the arterial lesions was the factor that most contributed to the need for iodine supplementation due to the difficulty to visualize the refill after a long arterial occlusion.

Although there are reports of complications with the use of intra-arterial CO2,(14) in our series no adverse events that could be related to this particular contrast media were observed, corroborating with other larger series previously published.(15) The use of CO2 manual injection without the need for pumps or injection systems is considered safe(16) and makes its use more affordable and easily reproducible.

In this series we observed that in the cases that we could not achieve technical success, this fact was related to the anatomy of the arterial lesions and technical difficulties, rather than to the type of contrast, as even with the iodine complementation we could not achieve technical success in four cases.

Despite the fact that the observer’s evaluation had a greater amount of good/fair notes, during the intraoperative period, the surgical team decided to use iodine supplementation in most of the cases to finish the procedures satisfactorily. Perhaps with the gain of experience in these complex cases, the procedures could be finished without iodine supplementation, as well as with the use of CO2 in TASC A and TASC B lesions.

In previous studies of our group, the gain of experience with the use of CO2 enabled us to understand that the injection of CO2 through catheters positioned more distally in the arteries, closer to the target lesion, allowed acquisition of superior quality images, but in TASC C and D lesions this technique did not dismiss the supplementation with ICM in most of the cases.

The scores attributed by both observers constitute a descriptive approach rather than an analytical approach and therefore are a limitation of our study.

In our study, seven patients showed an increase in creatinine clearance values in the postoperative period compared to the preoperative values. This improvement in renal function may be attributed to Intensive Care Unit support and postoperative fluid therapy, but some authors suggest that CO2 may have a renal protective effect. Criado et al.(8) reported that CO2 reduced contrast-induced nephropathy in patients who underwent endovascular repair of abdominal aortic aneurysm. Future studies with larger sample sizes are required to confirm the protective renal effect of CO2, even in patients with normal renal function.

We believe that CO2 can be an alternative in the treatment of TASC C and D lesions, because although the supplementation with iodine is commonly necessary and even expected, the burden of nephrotoxicity may be diminished, as its volume could be lowered. Aiming to decrease allergic reactions and potential nephrotoxicity in high-risk patients, the use of CO2 should be stimulated. The CO2 technique should work as a therapeutic weapon for vascular surgeons so they have the possibility of choosing the best contrast option for each patient at each moment of the procedures, instead of being limited to the use of only one type of contrast.

CONCLUSION

The use of CO2 in patients with TASC C and D lesions with no restriction for iodine contrast medium was an alternative that did not dismiss the need of iodine supplementation in most of the cases, but could decrease the potential nephrotoxicity of iodine contrast medium by the reduction of its volume in this group of high-risk patients for open revascularization surgery that continues to be a challenge for endovascular surgeons.

ACKNOWLEDGEMENTS

This work has been supported by Ministério da Saúde of Brazil.

REFERENCES

1. Wolosker N, Munia MA, Rosoky R, Fidelis RJ, Nakano L, Kauffman P, et al. Surgical treatment for intermittent claudication in patients who do not improve with clinical treatment. Arq Bras Cardiol. 2004;82(5):450-4, 445-9. [ Links ]

2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67. [ Links ]

3. Dominguez A 3rd, Bahadorani J, Reeves R, Mahmud E, Patel M. Endovascular therapy for critical limb ischemia. Expert Rev Cardiovasc Ther. 2015;13(4): 429-44. Review. [ Links ]

4. Baril DT, Chaer RA, Rhee RY, Makaroun MS, Marone LK. Endovascular interventions for TASC II D femoropopliteal lesions. J Vasc Surg. 2010;51(6):1406-12. [ Links ]

5. Grenville JL, Tan KT, Moshonov H, Rajan DK. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center. Vascular. 2015;23(1):31-40. [ Links ]

6. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113(14):1799-806. Review. [ Links ]

7. Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol. 2001;11(7):1267-75. Review. [ Links ]

8. Criado E, Upchurch GR, Young K, Rectenwald JE, Coleman DM, Eliason JL, et al. Endovascular aortic aneurysm repair with carbon dioxide-guided angiography in patients with renal insufficiency. J Vasc Surg. 2012;55(6):1570-5. [ Links ]

9. Kawasaki D, Fujii K, Fukunaga M, Masutani M, Nakata A, Masuyama T. Safety and efficacy of endovascular therapy with a simple homemade carbon dioxide delivery system in patients with ileofemoral artery diseases. Circ J. 2012;76(7):1722-8. [ Links ]

10. Fujihara M, Kawasaki D, Shintani Y, Fukunaga M, Nakama T, Koshida R, Higashimori A, Yokoi Y; CO2 Angiography Registry Investigators. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry. Catheter Cardiovasc Interv. 2015;85(5):870-7. [ Links ]

11. de Almeida Mendes C, de Arruda Martins A, Teivelis MP, Kuzniec S, Nishinari K, Krutman M, et al. Carbon dioxide is a cost-effective contrast medium to guide revascularization of TASC A and TASC B femoropopliteal occlusive disease. Ann Vasc Surg. 2014;28(6):1473-8. [ Links ]

12. Mendes Cde A, Wolosker N, Krutman M. A simple homemade carbon dioxide delivery system for endovascular procedures in the iliofemoral arteries. Circ J. 2013;77(3):831. [ Links ]

13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. [ Links ]

14. Johnson PL, Neperud J, Arnold J, Thomas J. Livedo reticularis and bowel ischemia after carbon dioxide arteriography in a patient with CREST syndrome. J Vasc Interv Radiol. 2011;22(3):395-9. [ Links ]

15. Moos JM, Ham SW, Han SM, Lew WK, Hua HT, Hood DB, et al. Safety of carbon dioxide digital subtraction angiography. Arch Surg. 2011;146(12):1428-32. [ Links ]

16. Cronin P, Patel JV, Kessel DO, Robertson I, McPherson SJ. Carbon dioxide angiography: a simple and safe system of delivery. Clin Radiol. 2005;60(1):123-5. [ Links ]

Received: February 25, 2016; Accepted: May 24, 2016

Corresponding author: Juliana Maria Fukuda – Avenida Albert Einstein, 627/701, building A1, 4th floor, room 423 – Morumbi – Zip code: 05652-900 – São Paulo, SP, Brazil – Phone: (55 11) 2151-5423 E-mail: ju_mfukuda@yahoo.com

Conflict of interest: none.

Creative Commons License  This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.